Plasma leptin concentration increases early during highly active antiretroviral therapy for acquired immunodeficiency syndrome, independent of body weight

Journal of Endocrinological Investigation

Volumn 28, Issue 5, 2005, Pages

  Pinzone, J J ^a,b   Fox, M L ^b   Sastry, M K ^a   Parenti, D M ^b,c   Simon, G L ^b,c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acquired immunodeficiency syndrome; AIDS; HAART; Highly active antiretroviral therapy; HIV; Human immunodeficiency virus; Leptin

Indexed keywords

CYTOKINE; DIDANOSINE; INDINAVIR; INTERLEUKIN 2; LAMIVUDINE; LEPTIN; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADIPOCYTE; ARTICLE; BODY MASS; BODY WEIGHT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIPODYSTROPHY; BLOOD; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHYSIOLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LEPTIN;

EID: 21444437264     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345372     Document Type: Article

References (18)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372: 425-32.
2. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995, 269: 543-6.
3. Mandel MA, Mahmoud AA. Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol 1978, 120: 1375-7.
4. Chandra RK, Au B. Spleen hemolytic plaque-forming cell response and generation of cytotoxic cells in genetically obese (CS7BI/6J ob/ob) mice. Int Arch Allergy Appl Immunol 1980, 62: 94-8.
5. Chandra RK. Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice. Am J Clin Nutr 1980, 33: 13-6.
6. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, and Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394: 897-901.
7. Caldefie-Chezet F, Poulin A, Tridon A, Sion B, Vasson MP. Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J Leukoc Biol 2001, 69: 414-8.
8. Busso N, So A, Chobaz-Peclat V, et al. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 2002, 168: 875-82.
9. Weigle DS, Bukowski TR, Foster DC, et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995, 96: 2065-70.
10. Larsson H, Elmstahl S, Berglund G, Ahren B. Evidence for leptin regulation of food intake in humans. J Clin Endocrinol Metab 1998, 83: 4382-5.
11. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997, 100: 270-8.
12. Scarpace PJ, Matheny M, Pollock BH, Tumer N. Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol 1997, 273: E226-30.
13. Zhou YT, Shimabukuro M, Koyama K, et al. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci USA 1997, 94: 6386-90.
14. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334: 292-5.
15. Yarasheski KE, Zachwieja JJ, Morgan MM, Powderly WG, Santiago JV, Landt M. Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. Metabolism 1997, 46: 303-5.
16. Paganelli R, Mezzaroma I, Mazzone AM, Pinter D, Aiuti F. Leptin levels in HIV-positive patients treated with HAART. AIDS 1999, 13: 2479.
17. Estrada V, Serrano-Rios M, Martinez-Larrad MT, et al. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002, 29: 32-40.
18. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002, 109: 1345-50.